Current Situation of 3D Bio-printing Technology
DOI:
https://doi.org/10.61173/q7cm4k84Keywords:
3D bioprinting, Healthcare, IndustryAbstract
To create functional tissues and probably fully functional human tissues, 3D bioprinting is a new technology that combines the efficiency of additive manufacturing with the difficulty of living techniques. Bioprinters can produce patient-specific constructs that resemble local cell structures and function using bio-inks made of living cells, biomaterials, and chemical cues. This paper provides a complete overview of the field, tracing its evolution from first scaffold-based approaches in the 1980s to breakthroughs such as AI-helped design, intraoperative bioprinting, and space-based tissue maturation. Regenerative medicine, disease modeling, pharmaceutical testing, aesthetic analysis, and cultured meat generation are just a few examples of the latest software. Despite these advances, challenges remain in achieving total vascularization, ensuring long-term cell viability, overcoming materials limitations, and addressing social and regulatory considerations. The paper also discusses potential directions, including on-demand tissue printing, global availability initiatives, and the integration of bioprinting with other renewable therapies. 3D bioprinting has the potential to revolutionize medicine and business by fostering cross-disciplinary collaboration and creativity, reducing the need for pet testing, and opening up new frontiers in both space and earth environments.
References
[1] Heinrich, M.A., Liu, W., Jimenez, A., et al. 3D Bioprinting: from Benches to Translational Applications. Small, 15(23), 1805510. Wiley, 2019.
[2] Yu, C., Ma, X., Zhu, W., et al. Current Advances in 3D Bioprinting Technology and Its Applications for Tissue Engineering. Polymers, 12(12), 2958. MDPI, 2020.
[3] Opentextbooks Clemson. Bioprinting: History and Developments. Open Textbooks, Clemson University, 2020.
[4] Wired. L’Oréal Partners with Organovo to 3D Print Skin. Wired, 2015.
[5] NASA. 3D Bioprinting aboard the International Space Station. NASA, 2023.
[6] U.S. Food and Drug Administration (FDA). 3D Bioprinting and Bio-Ink Regulation. FDA, 2021.
[7] National Institutes of Health (NIH). Synthetic Polymers in Bioprinting. NIH, 2023.
[8] U.S. National Library of Medicine. Hybrid Bio-Inks and Stem Cell Applications. NLM, 2023.
[9] World Health Organization (WHO). Emerging Technologies: 3D Bioprinting. WHO, 2023.
[10] Merck. Advances in 3D Bioprinted Liver Models. Merck, 2022.
[11] L’Oréal. Ethical Testing with 3D Printed Skin. L’Oréal, 2020.
[12] U.S. Food and Drug Administration (FDA). Guidance on 3D Bioprinted Medical Products. FDA, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
